NCT05883462View on ClinicalTrials.gov

Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH)

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2029

Conditions
Chronic Rhinosinusitis
Interventions
COMBINATION_PRODUCT

Airiver Nasal Drug Coated Balloon (DCB) Catheter.

The balloon is coated with a paclitaxel drug (3.5ug/mm2).

Trial Locations (1)

Unknown

RECRUITING

Sanatorio Americano Hospital, Asunción

Sponsors
All Listed Sponsors
lead

Airiver Medical, Inc.

INDUSTRY

NCT05883462 - Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH) | Biotech Hunter | Biotech Hunter